文献速递心血管胸部CT

心脏移植患者冠状动脉钙化的时间变化

Temporal changes in coronary artery calcium in heart transplantation patients.
PubMed 文献 · Eur Radiol · 2025-12-13

该回顾性单中心队列纳入116例心脏移植≥5年的成人受者,每年行心脏CT并随访≥4年,评估非增强CT的CAC评分变化。65例出现CAC进展,Ln(CAC+1)年均增加0.4(95%CI 0.4-0.5,p<0.001),相当于每年相对增加55%;供体心脏年龄是CAC进展的唯一独立相关因素(p<0.001)。

要点

  • 心脏移植受者中CAC进展常见,本队列116例中65例出现进展。
  • Ln(CAC+1)年均增加0.4(95%CI 0.4-0.5,p<0.001),相当于每年相对增加55%。
  • 供体心脏年龄是CAC进展的唯一独立相关因素(p<0.001)。

核心结论

  • 心脏移植后CAC进展常见,供体心脏年龄与之关联最强;受者与供体心脏年龄较轻、男性、缺血性心肌病与更快的CAC进展相关,提示需要更密切监测和更积极的心血管管理。

研究设计与样本

  • 回顾性单中心队列,纳入116例心脏移植≥5年的成人受者,每年行心脏CT并随访≥4年,采用非增强CT评估CAC评分,用广义线性混合模型评估CAC时间变化、逻辑回归识别与CAC进展相关的变量。

诊断标准与关键数值

  • 分组:无CAC进展组为所有CT扫描CAC=0,进展组为随访期间CAC任何增加。
  • 基线至末次CT,CAV评分0的患者比例由90%降至83%,CAV 1由3%升至6%,CAV 3由8%升至11%。
  • Ln(CAC+1)年均增加0.4(95%CI 0.4-0.5,p<0.001),相当于每年相对增加55%。
  • 与CAC进展存在显著交互的因素:基线CT时受者年龄(p=0.008)、供体心脏年龄(p<0.001)、性别(p=0.024)、受者缺血性心肌病(p<0.001)。
  • 仅供体心脏年龄与CAC进展独立相关(p<0.001)。

临床应用与阅片要点

  • 作者认为,常规CAC监测可能有助于识别心脏移植后心血管事件风险较高的患者,从而进行更密切监测和更积极的心血管管理,进而可能改善长期结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Coronary artery calcium (CAC) scoring is a well-established marker of atherosclerotic burden in the general population. Limited research has examined CAC progression and clinical implications in heart transplant (HT) recipients. We evaluated CAC progression in HT patients during long-term follow-up.

MATERIALS AND METHODS: We included adult HT recipients (≥ 5 years post-HT) from a retrospective single-center cohort undergoing annual cardiac CT with ≥ 4 years of follow-up. CAC scores were assessed using non-contrast CT. Patients were classified into two groups: no CAC progression (CAC = 0 across all CT scans) or any increase in CAC during follow-up. Generalized linear mixed models evaluated temporal changes in CAC; logistic regression identified variables associated with CAC progression.

RESULTS: Among 116 patients (median age at baseline CT: 52 [38-63] years, 62% male), 65 showed CAC progression. From baseline to final CT, the proportion of patients with cardiac allograft vasculopathy (CAV) score 0 declined (90-83%), while CAV 1 and 3 increased (3-6%; 8-11%). CAC scores showed an annual increase in Ln(CAC + 1) of 0.4 (95% CI: 0.4-0.5; p < 0.001), corresponding to a 55% relative yearly increase. Significant interactions were found with recipient age at baseline CT (p = 0.008), donor heart age (p < 0.001), sex (p = 0.024), and recipient ischemic cardiomyopathy (p < 0.001). Only donor heart age was independently associated with CAC progression (p < 0.001).

CONCLUSION: CAC progression is common post-HT, with donor heart age showing the strongest association. Younger recipient and donor heart age, male sex, and ischemic cardiomyopathy were associated with faster CAC progression, suggesting the need for closer surveillance and more aggressive cardiovascular management.

KEY POINTS: Question Longitudinal changes in CAC score were assessed in HT recipients to provide insights into cardiovascular risk and disease progression. Findings Over half of HT recipients showed CAC progression, which was significantly associated with donor age. Recipient age, sex, and primary diagnosis influenced progression rate. Clinical relevance Routine CAC monitoring may help identify patients at higher risk of cardiovascular events after heart transplantation, allowing for closer surveillance and more aggressive cardiovascular management, which in turn might improve long-term outcomes.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Sharma SP, van Dijk BCJ, Bos D, et al. Temporal changes in coronary artery calcium in heart transplantation patients. Eur Radiol. 2025. PMID: 41389083. doi:10.1007/s00330-025-12200-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。